Keros Therapeutics, Inc(NASDAQ:KROS) 
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, wh...
Website: http://www.kerostx.com
Founded: 2015
Full Time Employees: 32
CEO: Jasbir S. Seehra
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 10.07
H 10.36
L 9.64
C 9.98
V 1,543,370
10EMA 9.98
20EMA 9.98
60EMA 9.98
120EMA 9.98
250EMA 9.98